SynderBio, Inc

  Enabling a Rapid and Accurate Cancer Diagnosis

About Us
Founders
Meet The Founders
  1. Michael Henry, PhD
    Michael Henry is a cancer biologist at the University of Iowa, where he serves as an Associate Professor of Molecular Physiology and Biophysics, and is the Deputy Director of the Holden Comprehensive Cancer Center. Dr. Henry’s laboratory at the University of Iowa made the seminal discovery leading to the technology upon which SynderBio is based.
  2. Sarah Vigmostad, PhD
    Sarah Vigmostad is a fluid dynamics expert with experience in medical device design. She serves as an Associate Professor of Biomedical Engineering at the University of Iowa. Dr. Vigmostad’s collaboration with Dr. Henry led to the design and optimization of SynderBio’s current product under development.
  3. Mike Cable, PhD
    Mike Cable is a medical device entrepreneur (former CTO of Xenogen Corporation) currently living in the Bay Area. Dr. Cable has extensive experience and leadership at several startup technology companies, and has served as CEO, CTO, and VP-level responsibilities at numerous start-ups, including Fovi Optics, Nanomix, Xradia, and Matrix Sensors, Inc.